Keyphrases
16S Ribosomal RNA (16S rRNA)
19%
Bacteria Interaction
19%
Bacteroides
19%
Bifidobacterium
19%
Biological Therapy
33%
Bowel Control
11%
Cell Enrichment
9%
Clinical Phenotype
66%
Crohn's Disease
11%
Disease Course
8%
Dysregulation
11%
Fatty Acid Metabolism
19%
Fatty Acid Metabolism Genes
19%
Fecal Metabolites
16%
Fibrostenosis
16%
Fibrostenotic
19%
Gene Expression
19%
Gut Metabolome
33%
Gut Microbiome
33%
High-level Expression
19%
Host-microbe Interactions
66%
Immunity Genes
19%
Individual Specificity
8%
Inflammation-related Pathways
19%
Inflammatory Bowel Disease
100%
Inflammatory Genes
8%
Intestinal Biopsy
19%
Intestinal Cells
11%
Intestinal Epithelial Cells
8%
Intestinal Microbiota
19%
Macrophage Cells
8%
Metallothionein
19%
Microbial Composition
27%
Microbiome
25%
Microbiota
36%
Mucosa-associated Microbiota
27%
Mucosal Gene Expression
16%
Precision Medicine
19%
Predictive Value
33%
RNA Sequencing (RNA-seq)
19%
Ruminococcaceae
19%
Specific Interactions
19%
Stenotic Lesion
19%
Targeted Therapeutics
8%
Tissue Inflammation
8%
Tissue Location
8%
TNF-α Antagonists
27%
Transcriptional Network
38%
Transcriptomics
19%
Treatment Response
16%
Immunology and Microbiology
Bacteroides
11%
Bifidobacterium
14%
Biological Product
8%
Crohn's Disease
14%
Fatty Acid Metabolism
22%
Gene Expression
14%
Gut Microbiome
33%
Inflammatory Bowel Disease
100%
Intestine Flora
11%
Metabolite
8%
Metabolome
33%
Metagenomics
8%
Metallothionein
15%
Microbiome
25%
Microflora
55%
Mucosa
7%
RNA Sequencing
11%
Ruminococcaceae
11%
Sample Size
8%
Taxon
7%
Tumor Necrosis Factor
11%
Ustekinumab
8%
Vedolizumab
8%
